Skip to main content
. 2009 Sep 1;9(5):1–51.

Table 4: AHI reported in RCTs comparing MAS to placebo devices for the treatment of OSA.

Study Treatment Baseline AHI (h) Follow-up
AHI (h)
Mean
difference
between
baseline and
follow-up
Mean
difference
between MAS
and Placebo
Clinical
significance
Petri et al.
2008 (8)

Parallel arm
study (N=93)
MAS

Placebo
39.1 SD 23.8

32.6 SD 22.0
25.0 SD 27.5

31.7 SD 25.0
14.1
P <.001

0.9
P=.69
−6.7
P<.001
No

No
Blanco et al.
2005 (9)

Parallel arm
study (N=15)
MAS

Placebo
33.8 SD 14.7

24.0 SD 12.2
9.6 SD 12.1

11.7 SD 7.9
24.2
P <.01

12.3
P=.05
−2.1
NR
Yes

No
Barnes et al.
2004 (10)

Crossover study
(N=80)
MAS

Placebo
tablet
21.3 SD 13.9

21.3 SD 13.9
14.0 SD 11.7

20.3 SD 11.7
7.3
P <.001

1.0
P= NS
(no value reported)
−6.2
P<.001
No

No
Gotsopoulos
et al. 2004
(11-13)*

Crossover study
(N=73)
MAS

Placebo
26.9 SD 15.4

26.9 SD 15.4
12.2 SD 12.3

25.4 SD 14.5
14.7
NR

1.5
P=NS
(no value reported)
−12.3
NR
Yes

No
Johnston et al.
2002 (14)

Crossover study
(N=20)
MAS

Placebo
31.9 SD 21.2

31.9 SD 21.2
22.9 SD 22.8

37.7 SD 24.9
9.0
NR

−5.8
NR
−14.8
P=.011
No

No
Mehta et al.
2001 (15)

Crossover study
(N=24)
MAS

Placebo
27.0 SD17.0

27.0 SD 17.0
14.0 SD 9.8

30.0 SD 9.8
13.0
NR

−3.0
P=NS
(no value reported)
−16.0
P<.0001
No

No

Note: AHI, apnea hypopnea index; MAS, mandibular advancement splint; NR, not reported; SD, standard deviation

*

The same group of authors published results for a RCT between 2002-2005.